Efficacy, pharmacokinetics (PK) and safety results of a phase 3 clinical study of recombinant fusion protein linking coagulation factor IX with albumin (RIX-FP) in previously treated children with hemophilia B Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Kenet, G
  • Chambost, H
  • Male, C
  • Lambert, T
  • Alvarez-Roman, M
  • Halimeh, S
  • Chan, Anthony
  • Barnes, C
  • Chernova, T
  • Blatny, J
  • Mancuso, ME
  • Meunier, S
  • Komrska, V
  • Laws, H-J
  • Morfini, M
  • Curtain, J
  • Blazek, B
  • Voigt, C
  • Jacobs, I
  • Santagostino, E

publication date

  • June 1, 2015